| Name | Title | Contact Details |
|---|
We`re TD SYNNEX (NYSE: SNX), a leading distributor and solutions aggregator for the IT ecosystem. We`re 22,000 of the IT industry`s best and brightest, who share an unwavering passion for bringing compelling technology products, services and solutions to the world. We`re an innovative partner that helps our customers maximize the value of IT investments, demonstrate business outcomes and unlock growth opportunities. At our core, we`re a company that cares. We care about our partners, our co-workers, our investors and the world around us. And we`re committed to being a diverse, inclusive employer of choice and a good corporate citizen.
1 IT Source is a Clive, IA-based company in the Computers and Electronics sector.
Olympus Technology is a Whitestone, NY-based company in the Computers and Electronics sector.
Armis is the first agentless, enterprise-class security platform to address the new threat landscape of unmanaged and IoT devices. Fortune 1000 companies trust our unique out-of-band sensing technology to discover and analyze all managed, unmanaged, and IoT devices—from traditional devices like laptops and smartphones to new unmanaged smart devices like smart TVs, webcams, printers, HVAC systems, industrial robots, medical devices and more. Armis discovers devices on and off the network, continuously analyzes endpoint behavior to identify risks and attacks, and protects critical information and systems by identifying suspicious or malicious devices and quarantining them. Armis is a privately held company and headquartered in Palo Alto, California.
Cure Forward is the vision of a small team in Cambridge, MA. We wanted to create a platform to connect patients with genomic medicine, bringing the possibilities of precision medicine directly in reach. A way to use the best of technology to help people diagnosed with life-altering disease discover all of their options. We want to make it easy for patients to understand the root cause of their conditions and put the knowledge to work. Get their data, find treatment options, including clinical trials. We felt making this happen was worth staying up all night.